4//SEC Filing
MARCUS JOEL S 4
Accession 0000950170-24-021563
CIK 0001567514other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:57 PM ET
Size
16.8 KB
Accession
0000950170-24-021563
Insider Transaction Report
Form 4
MARCUS JOEL S
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-26$55.48/sh+16,757$929,678→ 65,990 total - Sale
Common Stock
2024-02-26$67.83/sh−8,371$567,805→ 57,619 total - Sale
Common Stock
2024-02-26$69.07/sh−17,658$1,219,638→ 39,961 total - Sale
Common Stock
2024-02-26$69.60/sh−299$20,810→ 39,662 total - Exercise/Conversion
Common Stock
2024-02-26$43.45/sh+20,000$869,000→ 49,233 total - Exercise/Conversion
Stock Option (right to buy)
2024-02-26−20,000→ 0 totalExercise: $43.45Exp: 2031-06-20→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-02-26−16,757→ 0 totalExercise: $55.48Exp: 2032-06-08→ Common Stock (16,757 underlying)
Holdings
- 10,000(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.53 to $68.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.53 to $69.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.53 to $69.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]Represents securities held of record by Alexandria Real Estate Equities, Inc. The reporting person is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria Real Estate Equities, Inc. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- [F5]All shares underlying this option have vested.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001216955
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 7:57 PM ET
- Size
- 16.8 KB